Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIK infusion during CABG surgery
IRCT2015012019470N13Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of glucose, human insulin and Potassium in coronary arteriosclerosis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Serum lactate and Central venous oxygenation. Started Feb 2016; status: completed.
02
Drugs
glucosehuman insulinPotassium
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT2015012019470N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015012019470N13.